Sequenom Corp fka SQNM

[barefootrunner]

Also, the bottom line with SQNM is that their technology works! The bad apples that mishandled the T21 test data were fired by the BOD, but the technology does WORK!

They have an estimated primary data collection date for a new T21 clinical trial in June of this year.

Bottom line is that there is no reason this should not be trading at the same levels it was before the data mishandling event - $15+

From a chart perspective, as well, next resistance = $15

GLTA!